Efficacy of Needle Prick Combined with Shenmai Pain Point Injection for Tennis Player’s Wrist Injury Tenosynovitis
Department of Physical, Northeastern University at Qinhuangdao, 1Graduate School of Northeastern University at Qinhuangdao, 2Parallel Robot and Mechatronic System Laboratory of Hebei Province, Yanshan University, 3Key Laboratory of Advanced Forging & Stamping Technology and Science of Ministry of National Education, Yanshan University, Qinhuangdao 066004, China
Y. MA, Parallel Robot and Mechatronic System Laboratory of Hebei Province, Yanshan University, China, E-mail: firstname.lastname@example.org
was observed and then analyzed the patient’s clinical outcomes. Grouping mode of random number table was adopted. Test I group and II group covered 1000 patients, which was also the case for the control group. The three groups of patients received different treatments for wrist injury tenosynovitis and all enrolled patients were tennis players. Test I group’s 1000 patients were treated with needle prick plus Shenmai pain point injection therapy, test II group’s 1000 patients were treated with needle prick therapy, while control group patients were treated with partial closure therapy. Under different therapeutic intervention models, clinical outcomes of the three groups of wrist injury tenosynovitis patients before and after treatment were compared. Seen from the findings, wrist injury tenosynovitis symptoms of all the patients enrolled in the controlled trial were eased in varying degrees after surgery. Seen from clinical treatment efficiency, test I group’s clinical treatment efficiency was significantly higher than that of test II group and control group (p<0.05); test II group’s clinical treatment efficiency was significantly higher than that of control group (p<0.05); differences between groups was significant, with statistical research value. In the experimental study, we have come to a conclusion that treatment of wrist injury tenosynovitis with needle prick plus Shenmai pain point injection is with significant effect, which is worthy of clinical promotion and reference.